• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neuroepidemiology . Characteristics Associated with Olfactory and Taste Disorders in COVID-19

tetano

Editor, Senior Moderator
Neuroepidemiology


. 2021 Jul 1;1-6.
doi: 10.1159/000517066. Online ahead of print.
Characteristics Associated with Olfactory and Taste Disorders in COVID-19


Simon Galmiche[SUP] 1 [/SUP], Timothée Bruel[SUP] 2 [/SUP], Yoann Madec[SUP] 3 [/SUP], Laura Tondeur[SUP] 3 [/SUP], Ludivine Grzelak[SUP] 2 4 5 [/SUP], Isabelle Staropoli[SUP] 2 [/SUP], Isabelle Cailleau[SUP] 6 [/SUP], Marie-Noëlle Ungeheuer[SUP] 7 [/SUP], Charlotte Renaudat[SUP] 7 [/SUP], Sandrine Fernandes Pellerin[SUP] 8 [/SUP], Bruno Hoen[SUP] 3 6 [/SUP], Olivier Schwartz[SUP] 2 4 5 9 [/SUP], Arnaud Fontanet[SUP] 3 10 [/SUP]



Affiliations

Abstract

Introduction: Olfactory and taste disorders (OTDs) have been reported in COVID-19 caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the mechanisms of which remain unclear. We conducted a detailed analysis of OTDs as part of 2 seroepidemiological investigations of COVID-19 outbreaks.
Methods: Two retrospective cohort studies were conducted in a high school and primary schools of Northern France following a COVID-19 epidemic in February-March 2020. Students, their relatives, and school staff were included. Anti-SARS-CoV-2 antibodies were identified using a flow-cytometry-based assay detecting anti-S IgG.
Results: Among 2,004 participants (median [IQR] age: 31 [11-43] years), 303 (15.2%) tested positive for SARS-CoV-2 antibodies. OTDs were present in 91 (30.0%) and 92 (30.3%) of them, respectively, and had 85.1 and 78.0% positive predictive values for SARS-CoV-2 infection, respectively. In seropositive participants, OTDs were independently associated with an age above 18 years, female gender, fatigue, and headache.
Conclusion: This study confirms the higher frequency of OTDs in females than males and adults than children. Their high predictive value for the diagnosis of COVID-19 suggests that they should be systematically searched for in patients with respiratory symptoms, fever, or headache. The association of OTDs with headache, not previously reported, suggests that they share a common mechanism, which deserves further investigation.

Keywords: Ageusia; Anosmia; COVID-19; Headache; Severe acute respiratory syndrome
 
Back
Top Bottom